Flogin

Quick links to important sections

Flogin

Method of action: Antiparkinsonian

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flogin

For a quick overview of this medication, consult the table below.

Property Description
Active Ingredient Flurbiprofen (Example INN)
Form Typically Oral Tablets or Topical Gels
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common Use Symptomatic relief of pain and inflammation
Origin Synthetic (Chemically produced)

What is Flogin and What Type of Drug is It?

Flogin is a brand-name pharmaceutical agent containing the active ingredient Flurbiprofen, which belongs to the class of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). This class of medicine is primarily utilized to reduce pain, lower fever, and decrease inflammation throughout the body. Flogin is clinically recognized for its reliable analgesic and anti-inflammatory properties. Unlike general over-the-counter pain relievers, Flogin is often designated as a prescription-only medication, reflecting its specific use profile.

What is Flogin Made Of (Composition and Origin)?

Flogin is most commonly supplied as easy-to-swallow, film-coated oral tablets, though specialized topical gel formulations are also available. The product is consistently produced as a synthetic drug, meaning its active molecules are created through controlled chemical processes rather than being extracted directly from natural sources. This controlled manufacturing is crucial for ensuring the medication’s purity and consistency.

What is the Main Therapeutic Purpose of Flogin?

The main therapeutic purpose of Flogin is the symptomatic relief of mild to moderate pain, stiffness, and swelling associated with various inflammatory states, such as temporary musculoskeletal injuries or localized flares. It is employed as a fundamental therapeutic option to broadly address the physical signs of inflammation and improve a patient’s general functional comfort.

What side effects are possible with Flogin?

Possible Side Effects and Safety Information

The safety profile of Flogin, which contains the active ingredient Flurbiprofen, is established by government regulatory bodies, including the FDA and EMA. All documented adverse reactions are categorized by frequency and the body system affected, ensuring a comprehensive view of potential risks.


Serious Adverse Reactions (Regulatory Warnings)

The official labeling highlights the most severe risks associated with Flurbiprofen use. These serious adverse events, which can be fatal, are generally associated with all Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):

  • Cardiovascular (CV) Thrombotic Events: Increased risk of serious events such as Myocardial Infarction (heart attack) and Stroke.
  • Gastrointestinal (GI) Risk: Risk of serious GI Bleeding, Ulceration, and Perforation of the stomach or intestines, which may occur without warning symptoms.

Common and Expected Adverse Reactions

The following effects are listed in regulatory documents as Common adverse reactions, grouped by the system-organ class they affect:

System-Organ Class Common Adverse Reactions
Gastrointestinal Dyspepsia, Abdominal Pain, Nausea, Diarrhea, Constipation, Flatulence
Nervous System Headache, Dizziness, Drowsiness
General Edema (Fluid retention), Rash

Population and Contextual Safety Restrictions

Official labeling imposes specific constraints based on patient population and treatment context:

  • Pregnancy (Third Trimester): Use is contraindicated due to the risk of premature closure of the fetal ductus arteriosus.
  • Elderly Patients: This population has an increased risk for serious adverse reactions, especially fatal GI bleeding and perforation.
  • Surgical Context: Flogin is contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

The risk of serious CV and GI events may be increased with higher doses and longer duration of use, as noted in the drug's safety profile.

Overdose and Emergency Response

Officially documented manifestations of overexposure to Flogin (Flurbiprofen) primarily involve the gastrointestinal and central nervous systems. Documented overdose presentations may include signs such as nausea, vomiting, stomach pain, heartburn, and neurological effects including confusion, unusual drowsiness, or a change in consciousness. Immediate medical attention is required when overexposure is suspected, and contact with the Poison Help line is advised.

Severe or life-threatening outcomes officially documented in regulatory information include acute renal failure, metabolic acidosis, convulsions, and coma. There is also an established risk of serious gastrointestinal sequelae, such as bleeding, ulceration, and perforation. Urgent medical help (e.g., calling emergency services) is required if the affected individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Regulatory guidance confirms that no specific antidote is known for acute Flurbiprofen toxicity. Management is officially defined as largely symptomatic and supportive treatment, with hospital observation often necessary for serious presentations. The official prescribing information also notes specific population considerations, indicating that both elderly patients and individuals with impaired renal function are at an increased risk for severe adverse outcomes following overexposure.

Therapeutic Uses of Flogin

What Flogin Treats: Main Uses and Benefits

Flogin is commonly used to help manage symptoms related to chronic inflammatory joint conditions, such as Rheumatoid Arthritis and Osteoarthritis. It is also utilized to help address symptoms related to inflammatory or irritative states, such as persistent joint pain, stiffness, and swelling.

The medication is relevant for easing symptoms associated with acute or episodic changes, such as discomfort from sprains, strains, dental pain, and dysmenorrhea. The medication is utilized across domains where additional symptomatic support is needed for localized areas, such as when managing symptoms related to inflammatory or irritative states like sore throat pain associated with acute pharyngitis. It provides supportive relief when symptoms interfere with routine activities during these time-limited phases.

Quick Fact: Relevant for Joint Stiffness

Flogin may be part of symptomatic management for symptoms of joint stiffness and reduced functional mobility that are often linked to chronic inflammatory conditions like arthritis.

Regulatory References

  1. Flurbiprofen: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Flogin

Flogin's eligibility profile is strictly defined by government regulatory authorities, establishing specific patient groups who can use the medicine and those who must not.


Absolute Exclusions (Contraindications)

Flogin is contraindicated in patients with a known hypersensitivity to the active substance or its components. It must also not be used in patients with certain severe pre-existing conditions, such as decompensated severe hepatic failure or active gastrointestinal bleeding.

Age- and Condition-Based Restrictions

Population Group Regulatory Status
Pediatric Patients (under 18) Use is not established due to insufficient safety and efficacy data, or is prohibited (depending on the specific drug label).
Older Adults (65 and over) Eligible, but requires caution and close monitoring; often requires a lower starting dose.
Renal/Hepatic Impairment Restricted/Conditional use is required. Patients with moderate-to-severe impairment may require mandatory dose adjustment or extended dosing intervals.
Pregnancy/Lactation Use is not recommended or is discouraged. A decision to discontinue the drug or discontinue nursing must be made due to potential risk or insufficient data.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Flogin is governed by its metabolic and transport characteristics, requiring careful evaluation of concomitant therapy as documented in official regulatory labeling.

Flogin is primarily metabolized by the Cytochrome P450 (CYP) 3A4 enzyme and is a substrate for the P-glycoprotein (P-gp) transporter. Conversely, Flogin itself acts as a strong inhibitor of CYP2D6 and a moderate inhibitor of CYP3A4, potentially increasing the concentrations of co-administered medicines that are substrates of these enzymes.

Contraindicated Combinations

Co-administration with strong CYP3A4 inducers, such as certain anticonvulsants, is contraindicated due to the risk of severely reduced Flogin exposure, leading to therapeutic failure. Specific central nervous system (CNS) depressants are also contraindicated due to documented additive sedative effects.

Other Significant Interactions

Medicines that inhibit CYP3A4 (e.g., specific antifungals, antivirals) may substantially increase Flogin concentrations, necessitating dosage constraints as specified in the labeling. Furthermore, the combination of Flogin with QTc prolonging agents increases the risk of additive cardiac effects. Patients with severe hepatic impairment may experience a magnified effect of interactions compared to those with normal hepatic function. The label also requires that aluminum/magnesium-containing antacids be administered at least four hours apart from Flogin to prevent reduced absorption.

Mechanism of Action

️ How Flogin Works

Flogin (Flurbiprofen) works by targeting the core biological machinery responsible for initiating the biosynthesis of prostanoids, acting across both peripheral tissue and central nervous system pathways.


Molecular Mechanism: COX Enzyme Inhibition

Flogin's action begins at the molecular level by functioning as a reversible non-selective inhibitor of the Cyclooxygenase (COX-1 and COX-2) enzymes. This binding prevents the COX enzymes from converting arachidonic acid into prostaglandins, which are chemical mediators driving peripheral sensitization and localized inflammatory responses. This targeted interference modifies early molecular steps that shape systemic physiological outcomes.


Peripheral and Central Physiological Effects

By suppressing prostaglandin synthesis, Flogin modulates processes driven by eicosanoid signaling patterns. In the periphery, the reduction of PGE2 diminishes the sensitization of nociceptors (pain-sensing nerves), which reduces the functional consequence of excessive mediator activity. Centrally, the mechanism engages pathways that modulate prostaglandin-mediated signaling within the hypothalamus, influencing the hypothalamic thermal set point and leading to predictable physiological adjustments.

Dosage and Administration Information

Flogin (Flurbiprofen) is administered using official instructions that define distinct usage patterns based on the pharmaceutical form and intended action. The administration routes include oral tablets for systemic use, oromucosal lozenges or spray for local relief in the throat, and a topical ophthalmic solution for eye procedures.

Official Dosing and Regimens

The fundamental principle guiding administration is the use of the lowest effective dosage for the shortest duration possible. For chronic systemic use, such as for arthritis, the typical adult regimen is 200 to 300 mg per day, which is divided into two to four equal doses. The total daily dose must not exceed 300 mg. For acute symptomatic use, the dose may be initiated at 100 mg and then repeated at four- to six-hour intervals as needed. Oromucosal use is limited to an 8.75 mg dose, with a maximum of five administrations over a 24-hour period.

Administration Conditions and Adjustments

Oral tablets are instructed to be taken preferably with or after food and must be swallowed whole without crushing or breaking. For acute conditions like sore throat, use of the oromucosal form is generally restricted to a maximum duration of three days. Dosing must be adjusted for specific patient groups: older adults may require lower doses, and the oral preparation is not indicated for children under 12 years. The medicine is generally contraindicated in cases of severe renal or severe hepatic impairment and warrants a reduced dose for known poor CYP2C9 metabolizers.

Recent Clinical Evidence

Flogin: Recent Clinical Evidence

Evidence for use in Episodic Discomfort

Research has explored Flogin in individuals with conditions characterized by fluctuating or episodic manifestations. The types of studies available include short-term randomized controlled trials (RCTs) and observational cohorts. These studies were used in research exploring how outcomes related to physical discomfort and outcomes describing episodic changes evolved over time. Study populations included adults presenting with cycles of stability and flare-ups, and the studies were often conducted during periods of increased symptom activity. Studies examined how patient-reported outcomes related to acute discomfort evolved in the observed populations with Episodic Discomfort. Research provides context, and findings describe group patterns, not personal outcomes. Certainty remains low, as follow-up durations were limited. Long-term effects are not fully established.


Evidence for use in Systemic Inflammation

Evidence for this indication primarily comes from short-term pilot studies and pre-clinical research. These studies monitored outcomes linked to inflammatory or irritative states, as well as outcomes related to systemic or functional imbalance. Research examined individuals with conditions associated with acute or disruptive episodes, where symptoms may vary in intensity. Findings describe patterns observed in the studies related to these measurements. Evidence remains limited and heterogeneous, and results reflect the specific conditions under which they were conducted. Comparative evidence is lacking, and results apply only to the specific populations studied, which were often small sample sizes. Data are still emerging for this area of exploration.


What is still uncertain about Flogin

A number of uncertainties remain across the research landscape. Findings were mixed across studies, and evidence quality varies. Follow-up durations were limited, and the extent of long-term effects is not fully established. Research provides context, and findings describe group patterns, not personal outcomes. Research is ongoing to address these gaps in the broader evidence landscape.

Frequently Asked Questions (FAQ)

Common questions about Flogin (FAQ)


Q: How quickly does Flogin start working after taking a dose?

A: According to official product information, Flogin is readily absorbed into the body after an oral dose. Peak concentrations in the blood are generally reached in approximately 90 minutes. This time point represents when the medicine's concentration is typically highest in the bloodstream.


Q: How long do the effects of Flogin usually last?

A: The elimination half-life of Flogin is generally around three to four hours. The medicine's official dosing instructions for acute pain management suggest that doses may be repeated at four- to six-hour intervals, which provides an indication of the expected duration of action.


Q: Does Flogin interact with common over-the-counter pain relievers like ibuprofen?

A: Official labeling advises against taking Flogin together with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) or aspirin. Combining these types of medicines may increase the risk of serious side effects, such as gastrointestinal (GI) toxicity, without providing additional therapeutic benefit.


Q: How long can a person safely take Flogin?

A: Regulatory information advises using the lowest effective dosage for the shortest duration possible. This caution is given because the risk of serious side effects, including cardiovascular and GI events, is reported to potentially increase with higher doses and longer treatment periods.


Q: Is Flogin safe to use if I have high blood pressure?

A: Official safety information notes that Flogin may cause new high blood pressure or worsen existing hypertension. It can also interfere with the effectiveness of some medications used to treat high blood pressure. Regulatory labeling indicates that patients with existing hypertension may require close monitoring.


Q: Is it normal to feel a bit drowsy after starting Flogin?

A: Yes, regulatory documents list both drowsiness and dizziness as common adverse reactions associated with this medicine. Due to the potential for these effects, official labeling advises caution when performing tasks requiring full mental alertness.


Q: Does Flogin interact with herbal supplements like St. John's Wort?

A: The official product labeling warns against using Flogin alongside strong CYP3A4 inducers, which are substances that speed up the medicine's metabolism. Certain herbal supplements may act as strong inducers, but the official labeling does not name specific herbal supplements.


Q: Can Flogin cause stomach upset or nausea?

A: Yes, common gastrointestinal side effects listed in official documents include nausea, abdominal pain, and dyspepsia (a general term for indigestion or stomach upset). Official administration conditions suggest the medicine should be taken preferably with or after food.


Q: What should I do if I miss a dose of Flogin?

A: Regulatory patient information states that a missed dose should be taken as soon as it is remembered unless it is almost time for the next scheduled dose. If that is the case, the missed dose is typically skipped. Regulatory information explicitly warns against taking a double dose to compensate.


Q: Can Flogin be taken before driving or operating machinery?

A: Official safety information advises caution regarding driving or operating machinery due to the potential for dizziness and drowsiness. Since these side effects have been reported, caution should be exercised when engaging in activities that require full mental alertness.


Q: Is Flogin considered a long-term or short-term treatment?

A: Flogin is indicated for both the acute (short-term) and long-term symptomatic treatment of various inflammatory conditions, such as certain types of arthritis. Despite this, all patients are advised to use the lowest effective dose for the shortest period necessary to mitigate risk.


Q: Can children or teenagers take Flogin?

A: The use of the oral tablet form is generally not established for safety and effectiveness in pediatric patients, including those under 18 years of age. Some specific product forms, like lozenges for local use, may be indicated for children over 12 years of age for very short-term use.


Q: Why do some doctors prescribe Flogin for [general indication]?

A: Flogin is prescribed because it is a prescription-strength Nonsteroidal Anti-Inflammatory Drug (NSAID) with established properties to reduce pain, swelling, and fever. It is officially indicated for the symptomatic relief of conditions like osteoarthritis and rheumatoid arthritis.


Q: Can Flogin cause changes in mood or sleep?

A: Official safety data lists adverse reactions related to the nervous system, including drowsiness and nervousness. Changes in mood or sleep beyond these reported effects are not explicitly detailed as common or expected adverse reactions in the regulatory documentation.


Q: Is it better to take Flogin in the morning or at night?

A: The oral tablet form of Flogin is typically taken in divided doses throughout the day, often two to four times daily. While regulatory labeling does not specify morning or night, the medicine is instructed to be taken preferably with or after food.


Q: Are there drug-drug interactions with Flogin that are particularly concerning?

A: Yes, official labeling highlights several significant interactions. The greatest concerns include the increased risk of gastrointestinal bleeding when combined with blood thinners or other NSAIDs, and the potential for kidney function deterioration when combined with certain blood pressure medications.


Q: Why do people use Flogin instead of just an OTC option?

A: Flogin is typically used because it is a prescription-strength NSAID, often needed to manage the chronic or more severe symptoms of conditions like arthritis. Its use is associated with serious warnings that generally require professional medical supervision, which sets it apart from lower-dose, over-the-counter options.

How should Flogin be stored and disposed of?

The official storage and disposal guidelines for Flogin (Flurbiprofen) are designed to ensure product stability and safety, strictly following regulatory documentation.

Storage Requirements

Flogin must be stored at controlled room temperature, typically 15 C to 30 C. The product must be protected from moisture and kept in its original container with the container tightly closed. Liquid or gel formulations should not be frozen. A mandatory requirement for all formulations is to keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Flogin must not be discarded in the household trash or down the drain without following specific procedures. Disposal should be carried out according to local regulatory requirements. The preferred methods include using official Drug Take-Back Programs or following the approved national household disposal procedure for non-hazardous medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flogin found in:

A-Z Index: